January 22, 2010

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

Global tobacco report outlines 21 challenges for 21st century

A new American Cancer Society report outlines 21 challenges and needs for global tobacco control, covering the wide range of issues to be addressed and expertise needed to reduce the rising tide of tobacco use worldwide, particularly in the low- and middle-income nations that are the target of the multinational tobacco industry. The report is published early online and will appear in the January/February issue of CA: A Cancer Journal for Clinicians.

The report's authors, led by Thomas Glynn, PhD, American Cancer Society director of Cancer Science and Trends, point out that the globalization of tobacco began with the European exploration of the New World more than 500 years ago. But it is only in the past 50 years that public health has responded to the death, disease, and economic disruption caused by . Tobacco now has at least 1.3 billion users and kills more than 14,500 people every day, while debilitating and sickening many times that number. The report lists activities, policies, and interventions that must be increased or in some cases decreased in order to be successful in reducing the rising tide of tobacco use.

INCREASE CHALLENGES

DECREASE CHALLENGES
The report says there are certainly many other challenges not discussed in the report and that, while "resources… will never be enough to address all of these challenges," actions taken with the resources currently available will have a significant effect on global health. Finally, the report points to an issue it says rises above all others when considering the potential to reverse the global epidemic: the need for skilled, dedicated people to address the issues outlined in the report.

More information: "The Globalization of Tobacco Use: 21 Challenges for the 21st Century," Thomas Glynn, PhD, John R. Seffrin, PhD, Otis W. Brawley, MD, Nathan Grey, MPH, H. Ross CA Cancer J Clin 2010 (DOI 10.3322/caac.20052).

Load comments (0)